← Latest Filings

M

Mpm Bioventures 2018, L.P.

Open-market buys

1

$20.0M total

Open-market sells

12

$3.6M total

Tracking since

Jan 2026

Activity timeline

Open-market sale — $206K

Entrada Therapeutics, Inc. · Sep 9, 2026

Open-market sale — $1.4M

Entrada Therapeutics, Inc. · Sep 8, 2026

Open-market trades from the last two years.

Holdings as last reported

10,260,064 Common Stock in AKTS

Held indirectly (See Footnote) · as of 2026-01-12

3,885,115 Common Stock in TRDA

Held indirectly (See Footnote) · as of 2026-09-09

Companies touched

Entrada Therapeutics, Inc.

Aktis Oncology, Inc.